FDA General
<ѻýҕl class="page-description">ѻýҕl>- By the Numbers
- Clinical Trials
- Environmental Health
- Equity in Medicine
- Ethics
- FDA General
- General Professional Issues
- Health Policy
- Medicaid
- Medical Education
- Medicare
- Military Medicine
- Opioids
- Practice Management
- Product Alert
- Public Health
- Repeal and Replace
- Stem Cell Research
- Washington Watch
- Work Force
More in FDA General
Broad indication doubles the number of patients eligible for adjuvant CDK4/6 inhibition
Sep 17, 2024
38% of patients treated with IL-13 blocker achieved clear or almost-clear skin at 16 weeks
Sep 13, 2024
Agency advisors put their foot down on shaky science for Ocaliva in primary biliary cholangitis
Sep 13, 2024
Lawmakers also queried officials about a menthol cigarette rule and labeling of milk alternatives
Sep 10, 2024